These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32010970)

  • 1. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma.
    Wu M; Miao H; Fu R; Zhang J; Zheng W
    Curr Mol Pharmacol; 2020; 13(4):261-272. PubMed ID: 32091349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice.
    Kang MJ; Lee S; Jung U; Mandal C; Park H; Stetler-Stevenson WG; Kim YS; Moon JW; Park SH; Oh J
    Am J Pathol; 2021 Dec; 191(12):2219-2230. PubMed ID: 34428424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor.
    Das D; Fayazzadeh E; Li X; Koirala N; Wadera A; Lang M; Zernic M; Panick C; Nesbitt P; McLennan G
    J Cell Physiol; 2020 Sep; 235(9):6167-6182. PubMed ID: 31975386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
    Song Y; Kim SH; Kim KM; Choi EK; Kim J; Seo HR
    Sci Rep; 2016 Nov; 6():36750. PubMed ID: 27853186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
    Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
    Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model.
    Geng ZM; Li QH; Li WZ; Zheng JB; Shah V
    Cell Biochem Biophys; 2014 Sep; 70(1):337-47. PubMed ID: 24676678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma.
    Coulouarn C; Clément B
    J Hepatol; 2014 Jun; 60(6):1306-9. PubMed ID: 24530649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
    Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
    J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.
    Ezhilarasan D; Najimi M
    Crit Rev Oncol Hematol; 2023 Feb; 182():103902. PubMed ID: 36621514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
    Yu Z; Guo J; Liu Y; Wang M; Liu Z; Gao Y; Huang L
    J Nanobiotechnology; 2022 Jan; 20(1):9. PubMed ID: 34983554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
    Chen Y; Qian B; Sun X; Kang Z; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
    Cancer Lett; 2021 Feb; 499():243-254. PubMed ID: 33246092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
    Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
    Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
    Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
    Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.